Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lumry

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Allergy and Asthma Proceedings|September 9, 2014
Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world settingMarcus Maurer, Hilary J Longhurst, Vincent Fabien, et al.
Journal of Asthma and Allergy|May 11, 2026
Drug Patterns and Economic Costs Among Patients with Hereditary AngioedemaEmily Kutrieb, Derek Weycker, Montserrat Vera-Llonch, et al.
Allergy and Asthma Proceedings|June 5, 2003
Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthmaCharles Banov, William C Howland, William R Lumry, et al.
Allergy and Asthma Proceedings|November 10, 2021
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasoneDavid P Skoner, Eli O Meltzer, Jonathan Skoner, et al.
International Archives of Allergy and Immunology|November 12, 2015
Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3William R Lumry, Henriette Farkas, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology|June 1, 1983
Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administrationW R Lumry, J G Curd, R S Zeiger, et al.
Allergy and Asthma Proceedings|May 16, 2012
Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsRichard G Gower, William R Lumry, Mark A Davis-Lorton, et al.
Vox Sanguinis|August 9, 2022
Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency diseaseGergely Kriván, Michael Borte, James B Harris, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 7, 2019
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancyDumitru Moldovan, Jonathan A Bernstein, Roman Hakl, et al.
Orphanet Journal of Rare Diseases|June 22, 2024
An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedemaRobbin Itzler, William R Lumry, John Sears, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Allergy and Asthma Proceedings|September 9, 2014
Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world settingMarcus Maurer, Hilary J Longhurst, Vincent Fabien, et al.
Journal of Asthma and Allergy|May 11, 2026
Drug Patterns and Economic Costs Among Patients with Hereditary AngioedemaEmily Kutrieb, Derek Weycker, Montserrat Vera-Llonch, et al.
Allergy and Asthma Proceedings|June 5, 2003
Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthmaCharles Banov, William C Howland, William R Lumry, et al.
Allergy and Asthma Proceedings|November 10, 2021
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasoneDavid P Skoner, Eli O Meltzer, Jonathan Skoner, et al.
International Archives of Allergy and Immunology|November 12, 2015
Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3William R Lumry, Henriette Farkas, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology|June 1, 1983
Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administrationW R Lumry, J G Curd, R S Zeiger, et al.
Allergy and Asthma Proceedings|May 16, 2012
Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsRichard G Gower, William R Lumry, Mark A Davis-Lorton, et al.
Vox Sanguinis|August 9, 2022
Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency diseaseGergely Kriván, Michael Borte, James B Harris, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 7, 2019
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancyDumitru Moldovan, Jonathan A Bernstein, Roman Hakl, et al.
Orphanet Journal of Rare Diseases|June 22, 2024
An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedemaRobbin Itzler, William R Lumry, John Sears, et al.
Pageof 14